Pharmaceuticals

Rheumatoid Arthritis Drugs Market Forecast: What to Expect by 2029

November 7, 2025November 7, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Rheumatoid Arthritis Drugs Market Between 2025 And 2029?

The rheumatoid arthritis drugs market has experienced a marginal decline in size over recent years. It is projected to change from $60.3 billion in 2024 to $60.1 billion by 2025, demonstrating a compound annual growth rate (CAGR) of -0.3%. Historically, the market’s expansion was driven by factors including increasing disease prevalence, growth in healthcare infrastructure, various awareness and education initiatives, government support and programs, and strategic collaborations.

The rheumatoid arthritis drugs market is projected to demonstrate consistent expansion in the coming years. Its size is expected to reach $65.34 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 2.1%. This anticipated growth during the forecast period can be primarily attributed to factors such as personalized medicine trends, the expansion of emerging markets, advancements in pipeline development, a concentrated effort on combination therapies, and a rise in healthcare spending. Significant trends identified for this period include the continued dominance of biological therapies, the influence of biosimilars, ongoing progress in personalized medicine, an increase in oral therapies, and a heightened focus on early diagnosis and intervention.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10120&type=smp

What Are The Key Drivers Of Growth In The Rheumatoid Arthritis Drugs Market?

An anticipated increase in arthritis cases is projected to drive the expansion of the rheumatoid arthritis drugs market in the future. Rheumatoid arthritis is defined as an autoimmune and inflammatory disorder where the immune system mistakenly attacks healthy bodily cells, resulting in inflammation (characterized by painful swelling) in the affected regions. Effective treatment for RA is available through rheumatoid arthritis drugs and various self-management approaches. These medications alleviate pain, improve joint mobility, and prevent the progression of the illness. For example, in February 2024, data from the National Center for Health Statistics, a US government agency, indicated that in 2022, the age-adjusted prevalence of diagnosed arthritis among adults stood at 18.9%, with women (21.5%) experiencing a higher likelihood of affliction compared to men (16.1%). The occurrence rate notably increased with advancing age, moving from 3.6% in adults between 18–34 years old to 53.9% in individuals aged 75 and older. Consequently, the increasing incidence of arthritis cases is anticipated to stimulate the rheumatoid arthritis drug market.

How Is The Rheumatoid Arthritis Drugs Market Classified Into Different Segments?

The rheumatoid arthritis drugs market covered in this report is segmented –

1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Biologic Response Modifiers (BRMs), Other Drug Types

2) By Route Of Administration: Oral, Parenteral, Topical, Other Route Of Administrations

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Indomethacin

2) By Corticosteroids: Prednisone, Methylprednisolone, Dexamethasone

3) By Disease-Modifying Antirheumatic Drugs: Methotrexate, Sulfasalazine, Hydroxychloroquine, Leflunomide

4) By Biologic Response Modifiers: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, B-cell Inhibitors

5) By Other Drug Types: Janus Kinase Inhibitors, Other Novel Therapies

Which Key Trends Are Expected To Influence The Rheumatoid Arthritis Drugs Market In The Coming Years?

The rheumatoid arthritis drug market is experiencing a significant and growing trend toward product innovations. Companies operating in this market are implementing new product launches to sustain their competitive position. For instance, R-Pharm, a Russian private high-tech pharmaceutical company, launched Olokizumab in August 2022. This product is a humanized monoclonal antibody specifically designed to target the cytokine interleukin-6. This messenger molecule plays a role in the advancement of joint destruction in rheumatoid arthritis and, akin to TNF (tumor necrosis factor), elicits inflammatory responses in the body, which helps to lower disease activity in many rheumatoid arthritis patients.

Which Leading Players Are Enhancing Their Rheumatoid Arthritis Drugs Market Presence Worldwide?

Major companies operating in the rheumatoid arthritis drugs market include Pfizer Inc., Abbvie Inc., Amgen Inc., Novartis AG, Boehringer Ingelheim International GmbH, Eli Lilly and Company, F-Hoffmann La Roche AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Merck & Co Inc., Johnson & Johnson Inc., Bayer AG, Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., Sanofi S.A, Biogen Inc., Regeneron Pharmaceuticals Inc., Galapagos NV, Abbott Laboratories, Takeda Pharmaceutical Company Limited, Mitsubishi Tanabe Pharma Corporation, UCB S.A., Astellas Pharma Inc., Corbus Pharmaceuticals Holdings Inc., Roche Holding AG, Daiichi Sankyo Company Limited, Mallinckrodt Pharmaceuticals, Gilead Sciences Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/rheumatoid-arthritis-drugs-global-market-report

How Does The Rheumatoid Arthritis Drugs Market Perform Across Key Geographic Regions?

North America was the largest region in the rheumatoid arthritis drugs market in 2024.North America is expected to be the fastest-growing region in the global rheumatoid arthritis market report during the forecast period. The regions covered in the rheumatoid arthritis drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Rheumatoid Arthritis Drugs Market Report:

https://www.thebusinessresearchcompany.com/customise?id=10120&type=smp

Browse Through More Reports Similar to the Global Rheumatoid Arthritis Drugs Market 2025, By The Business Research Company

Data Protection As A Service Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/data-protection-as-a-service-global-market-report

Cloud Security Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cloud-security-global-market-report

Application Security Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/application-security-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795